Search Results - "Vedi, Satish"

Refine Results
  1. 1

    Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine by Gupta, Nancy, Garg, Saurabh, Vedi, Satish, Kunimoto, Dennis Y, Kumar, Rakesh, Agrawal, Babita

    Published in Frontiers in immunology (16-10-2018)
    “…Tuberculosis (TB), an infectious disease caused by ( ), kills 5,000 people per day globally. Rapid development and spread of various multi drug-resistant…”
    Get full text
    Journal Article
  2. 2

    Heterologous Immunity between Adenoviruses and Hepatitis C Virus: A New Paradigm in HCV Immunity and Vaccines by Singh, Shakti, Vedi, Satish, Samrat, Subodh Kumar, Li, Wen, Kumar, Rakesh, Agrawal, Babita

    Published in PloS one (11-01-2016)
    “…Adenoviruses (Ad) are commonly used as vectors for gene therapy and/or vaccine delivery. Recombinant Ad vectors are being tested as vaccines for many…”
    Get full text
    Journal Article
  3. 3

    Unsolved Puzzles Surrounding HCV Immunity: Heterologous Immunity Adds Another Dimension by Agrawal, Babita, Singh, Shakti, Gupta, Nancy, Li, Wen, Vedi, Satish, Kumar, Rakesh

    “…Chronic infection with hepatitis C virus (HCV) afflicts 3% of the world's population and can lead to serious and late-stage liver diseases. Developing a…”
    Get full text
    Journal Article
  4. 4

    Harnessing Innate Immunity to Treat Mycobacterium tuberculosis Infections: Heat-Killed Caulobacter crescentus as a Novel Biotherapeutic by Gupta, Nancy, Vedi, Satish, Garg, Saurabh, Loo, Eric, Li, Jie, Kunimoto, Dennis Y, Kumar, Rakesh, Agrawal, Babita

    Published in Cells (Basel, Switzerland) (09-02-2023)
    “…Tuberculosis, caused by ( ), is a serious and devastating infectious disease worldwide. Approximately a quarter of the world population harbors latent…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Heterologous Immunity between Adenoviruses and Hepatitis C Virus (HCV): Recombinant Adenovirus Vaccine Vectors Containing Antigens from Unrelated Pathogens Induce Cross-Reactive Immunity Against HCV Antigens by Agrawal, Babita, Gupta, Nancy, Vedi, Satish, Singh, Shakti, Li, Wen, Garg, Saurabh, Li, Jie, Kumar, Rakesh

    Published in Cells (Basel, Switzerland) (26-05-2019)
    “…Host immune responses play an important role in the outcome of infection with hepatitis C virus (HCV). They can lead to viral clearance and a positive outcome,…”
    Get full text
    Journal Article
  7. 7

    Bacterially expressed recombinant envelope protein domain III of Japanese encephalitis virus (rJEV-DIII) elicits Th1 type of immune response in BALB/c mice by Verma, Shailendra Kumar, Kumar, Subodh, Gupta, Nimesh, Vedi, Satish, Bhattacharya, Shailja Misra, Lakshmana Rao, P.V

    Published in Vaccine (16-11-2009)
    “…Abstract Japanese encephalitis is a major cause of encephalitis in Asia. Cases occur largely in rural areas of the South and East Asian region resulting in…”
    Get full text
    Journal Article
  8. 8

    Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis : Routes of immunization and TLR agonists critically impact vaccine’s efficacy by Gupta, Nancy, Vedi, Satish, Kunimoto, Dennis Y, Agrawal, Babita, Kumar, Rakesh

    Published in Vaccine (04-11-2016)
    “…Highlights • Novel subunit vaccine for Mtb by using simple lipid (palmitic acid) modified peptides from ESAT-6 protein. • Lipopeptides induce significant…”
    Get full text
    Journal Article
  9. 9

    Vaccination with 73 kDa recombinant heavy chain myosin generates high level of protection against Brugia malayi challenge in jird and mastomys models by Vedi, Satish, Dangi, Anil, Hajela, Krishnan, Misra-Bhattacharya, Shailja

    Published in Vaccine (05-11-2008)
    “…Abstract We have earlier reported identification, expression and purification of a 2.0 kb cDNA clone coding for Brugia malayi heavy chain myosin which…”
    Get full text
    Journal Article
  10. 10

    Harnessing Innate Immunity to Treat IMycobacterium tuberculosis/I Infections: Heat-Killed ICaulobacter crescentus/I as a Novel Biotherapeutic by Gupta, Nancy, Vedi, Satish, Garg, Saurabh, Loo, Eric, Li, Jie, Kunimoto, Dennis Y, Kumar, Rakesh, Agrawal, Babita

    Published in Cells (Basel, Switzerland) (01-02-2023)
    “…Tuberculosis, caused by Mycobacterium tuberculosis (Mtb), is a serious and devastating infectious disease worldwide. Approximately a quarter of the world…”
    Get full text
    Journal Article
  11. 11

    4'-Substituted pyrimidine nucleosides lacking 5'-hydroxyl function as potential anti-HCV agents by Shakya, Neeraj, Vedi, Satish, Liang, Chao, Yang, Fang, Agrawal, Babita, Kumar, Rakesh

    Published in Bioorganic & medicinal chemistry letters (01-03-2014)
    “…Hepatitis C virus (HCV) infection is one of the major health problems worldwide. If left untreated, it leads to liver cirrhosis, liver cancer and death…”
    Get full text
    Journal Article
  12. 12

    Recombinant adenoviral vector expressing HCV NS4 induces protective immune responses in a mouse model of Vaccinia-HCV virus infection: A dose and route conundrum by Singh, Shakti, Vedi, Satish, Li, Wen, Samrat, Subodh Kumar, Kumar, Rakesh, Agrawal, Babita

    Published in Vaccine (13-05-2014)
    “…Highlights • Recombinant adenoviral vector containing HCV NS4 antigen can induce both cellular and humoral immune responses. • The dose and route of…”
    Get full text
    Journal Article
  13. 13

    Heterologous Immunity and Hepatitis C Virus: Impact on Natural Infection, Pathogenesis and Vaccine Design by Babita Agrawal, Shakti Singh, Nancy Gupta, Satish Vedi, Wen Li, Saurabh Garg, Jie Li, Rakesh Kumar

    Published in Proceedings (01-06-2020)
    “…Chronic infection with the hepatitis C virus (HCV) afflicts 1%–3% of the world’s population and can lead to serious and late-stage liver diseases. Developing a…”
    Get full text
    Journal Article
  14. 14

    Improvement in the antifilarial efficacy of doxycycline and rifampicin by combination therapy and drug delivery approach by Dangi, Anil, Dwivedi, Varun, Vedi, Satish, Owais, Mohammad, Misra-Bhattacharya, Shailja

    Published in Journal of drug targeting (01-06-2010)
    “…The present investigation deals with the evaluation of antifilarial efficacy of liposome entrapped antiwolbachial antibiotics doxycycline and rifampicin (5…”
    Get full text
    Journal Article
  15. 15

    A new class of pyrimidine nucleosides: inhibitors of hepatitis B and C viruses by Shakya, Neeraj, Vedi, Satish, Liang, Chao, Agrawal, Babita, Lorne Tyrrell, D., Kumar, Rakesh

    Published in Bioorganic & medicinal chemistry letters (15-10-2012)
    “…Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are major health threats worldwide leading to liver cirrhosis, liver cancer and mortality…”
    Get full text
    Journal Article
  16. 16

    Vaccination with 73kDa recombinant heavy chain myosin generates high level of protection againstBrugia malayichallenge in jird and mastomys models by Vedi, Satish, Dangi, Anil, Hajela, Krishnan, Misra-Bhattacharya, Shailja

    Published in Vaccine (05-11-2008)
    “…We have earlier reported identification, expression and purification of a 2.0kb cDNA clone coding forBrugia malayiheavy chain myosin which exhibited strong…”
    Get full text
    Journal Article
  17. 17

    Vaccination with 73kDa recombinant heavy chain myosin generates high level of protection against Brugia malayi challenge in jird and mastomys models by Vedi, Satish, Dangi, Anil, Hajela, Krishnan, Misra-Bhattacharya, Shailja

    Published in Vaccine (05-11-2008)
    “…We have earlier reported identification, expression and purification of a 2.0kb cDNA clone coding for Brugia malayi heavy chain myosin which exhibited strong…”
    Get full text
    Journal Article
  18. 18

    Heterologous Immunity between Adenoviruses and Hepatitis C Virus: A New Paradigm in HCV Immunity and Vaccines: e0146404 by Singh, Shakti, Vedi, Satish, Samrat, Subodh Kumar, Li, Wen, Kumar, Rakesh, Agrawal, Babita

    Published in PloS one (01-01-2016)
    “…Adenoviruses (Ad) are commonly used as vectors for gene therapy and/or vaccine delivery. Recombinant Ad vectors are being tested as vaccines for many…”
    Get full text
    Journal Article
  19. 19

    Adjuvanticity and protective immunity of Plasmodium yoelii nigeriensis blood-stage soluble antigens encapsulated in fusogenic liposome by Dwivedi, Varun, Vasco, Azevedo, Vedi, Satish, Dangi, Anil, Arif, Khan, Bhattacharya, Shailja Mishra, Owais, Mohammad

    Published in Vaccine (14-01-2009)
    “…Abstract In our previous studies we established fusogenic properties of lipids isolated from edible yeast Saccharomyces cerevisiae ( S. cerevisiae ). We…”
    Get full text
    Journal Article
  20. 20

    Tetracycline treatment targeting Wolbachia affects expression of an array of proteins in Brugia malayi parasite by Dangi, Anil, Vedi, Satish, Nag, Jeetendra Kumar, Paithankar, Sameer, Singh, Mahendra Pratap, Kar, Santosh Kumar, Dube, Anuradha, Misra-Bhattacharya, Shailja

    Published in Proteomics (Weinheim) (01-09-2009)
    “…Wolbachia is an intracellular endosymbiont of Brugia malayi parasite whose presence is essential for the survival of the parasite. Treatment of B…”
    Get full text
    Journal Article